Navigation Links
HIV makes protein that may help virus's resurgence
Date:2/25/2011

uses control their infectivity," said Finkel.

The researchers carried out their work in HeLa cells, a human cell line long used in cell studies, as well as in human T cells, immune cells found in the blood. They identified two proteins, Brd4 and Cdk9, which interact with Vif. This interaction was a new discovery, although the proteins were already known to regulate the progression of the cell cycle.

Identifying Vif's cellular partners may also implicate them as potential targets for therapy. "If we can interrupt the activity of Brd4 or Cdk9, we may be able to prevent latent infection from becoming active," said Finkel. "Alternatively, by harnessing Brd4 or Cdk9, we may be able to drive cells out of latency and make the virus susceptible to anti-HIV drugs." She added that early preclinical testing of inhibitors is getting under way for other conditions, but cautioned that it is too early to foresee whether, or how soon, her research findings will lead to clinical treatments for HIV.


'/>"/>

Contact: John Ascenzi
ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia
Source:Eurekalert

Page: 1 2

Related biology news :

1. Trustee makes donation to start new solar energy research center at Rensselaer
2. What makes an axon an axon?
3. Feed a cold, feed a fever: Research shows calorie cut makes it harder to fight flu
4. Fly guy makes memory breakthrough
5. Our unconscious brain makes the best decisions possible
6. Biophysical Reviews makes debut in 2009
7. Tree lizard’s quick release escape system makes jumpers turn somersaults
8. Rett Syndrome Research Trust advisor makes significant discovery
9. Peptides-on-demand: McGill researchers radical new green chemistry makes the impossible possible
10. Mount Sinai Hospital researcher makes stem cell breakthrough
11. Red wine vs. white? It makes no difference when it comes to breast-cancer risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015   ... medication safety systems and image documentation solutions ... of comprehensive, technologically-advanced automation solutions, is pleased ... integration. The Codonics® Safe Label System® (SLS), ... in conjunction with the Omnicell Anesthesia Workstation, ...
(Date:5/25/2015)... market for wearable technologies is considered to be in ... several trials and prototypes. The release of the Apple ... interest in wearables as well as accelerate sales of ... in turn will spur greater innovation from other players ... and distributors. Photo - http://photos.prnewswire.com/prnh/20150526/218287 ...
(Date:5/22/2015)... According to a new market ... Thermal, Emotion, Forensic), by Software (Middleware, Databases), by Hardware (Cameras, ... and Home) - Global Forecast to 2020", published by ... in 2015 to $6.19 Billion by 2020, at a ... data Tables and   43 Figures spread through 140 ...
Breaking Biology News(10 mins):Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3
... the word "doctor" to mean "all-knowing," unfortunately, this will ... of medical professionals sometimes leads to devastating misdiagnoses that ... their patients. , But there is hope for better, ... technologies, and one Florida State University researcher is putting ...
... data for E7389 in the treatment of advanced, refractory ... E7389 is a synthetic analog of halichondrin B ... studies to have highly potent anti-cancer activity in vitro ... a type of marine sponge. , This study was ...
... shown that the immune-stimulating hormone known as interleukin-12 ... immune-system protein, as an experimental therapy for some ... to stimulate the immune system to attack certain ... sometimes used to treat melanoma, advanced kidney cancer ...
Cached Biology News:Making medicine 'smarter' 2Eisai announces Phase II data on E7389, a potential new therapy for the treatment of breast cancer 2Study shows combination of immune substances to be safe 2
(Date:6/1/2015)...  Berg, a biopharmaceutical company committed to uncovering health ... from its trials using its cancer drug BPM 31510 ... triple negative breast cancer, at the 51 st ... (ASCO), May 29 – June 2 in ... one of the first cancer drugs guided in development ...
(Date:6/1/2015)... , June 1, 2015  Albany Molecular ... today that it has signed a collaborative ... co-market their structure-based drug discovery services to ... of the three-year agreement, AMRI gains access ... and capabilities. HarkerBIO,s customers will be able ...
(Date:6/1/2015)... DUBLIN , May 29, 2015 /PRNewswire/ ... announced the addition of the "2015 ... Market" report to their offering. ... tables, and provides a comprehensive analysis of ... dynamics, size, growth, regulatory requirements, technological trends, ...
(Date:6/1/2015)... 29, 2015 Research and Markets ( ... "2015 Strategies in the UK Flow Cytometry ... This report presents a comprehensive analysis of the ... issues pertaining to the French flow cytometry practice, ... and technological trends with significant market impact during ...
Breaking Biology Technology:Berg Presents Data On BPM 31510 Solid Tumor Trial At ASCO Annual Meeting That Reveals The Promise Of Metabolically Driven Therapy 2Berg Presents Data On BPM 31510 Solid Tumor Trial At ASCO Annual Meeting That Reveals The Promise Of Metabolically Driven Therapy 3AMRI and HarkerBIO Ink Collaborative Agreement in Buffalo, N.Y. 2AMRI and HarkerBIO Ink Collaborative Agreement in Buffalo, N.Y. 3Strategies in the UK Flow Cytometry Market 2015 2
... July 7 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc.,("China-Biotics", the "Company") (Nasdaq: CHBT ... , today provides,further updates on the Company,s bulk additive operation. , ... China-Biotics gained ... and the total number of bulk customers increased to 39 by the ...
... , ... that from a single platform, scientists can efficiently profile lead compounds in their own ... ... -- Promega Corporation has partnered with SignalChem Pharmaceuticals to launch a flexible and complete ...
... CLEVELAND , July 7 DATATRAK International, Inc. ... eClinical solutions for the clinical trials industry, today announced that ... approximately $0.53 per share with certain members of ... sold pursuant to the private placement are restricted securities and ...
Cached Biology Technology:China-Biotics Provides Further Updates on Qingpu New Facility 2China-Biotics Provides Further Updates on Qingpu New Facility 3Promega Now Offers Complete Solution for Profiling Kinase Inhibitor Compounds Against the Human Kinome 2DATATRAK Completes Sale of 357,857 Common Shares to Directors and Management 2DATATRAK Completes Sale of 357,857 Common Shares to Directors and Management 3
supplied with 10x reaction buffer...
... from yeast/leuconostoc overproducer ATP: D-hexose ... 2.7.1.1/1.1.1.49. One unit of HK ... D-glucose in 1 min at ... unit of G6P-DH will oxidize ...
Request Info...
... This product is expected to ... mammalian species but has not been ... single precipitin line against partially purified ... to react with all forms of ...
Biology Products: